CH2), 4.00 (2H, t, J 6.3, OCH3), 6.81 (2H, d, J 8.4, ArH), 7.10 (2H,
d, J 8.4, ArH). dC (CDCl3) 20.4 (CH3), 25.4 (CH3), 29.7 (CH2),
39.2 (CH2), 49.2 (CH3), 65.0 (CH2), 67.2 (CH2), 67.5 (CH2), 73.8
(C), 114.3 (CH), 129.8 (CH), 130.0 (C), 156.9 (C).
16e (Found: [M+NH4]+ 184.2170. C10H14O2 (M) requires
[M+NH4]+ 184.2170) nmax(neat)/cm-1 3273, 2953, 2872, 1513,
1471, 827; dH (CDCl3) 2.00–2.07 (2H, quintet, J 5.9, CH2), 3.89
(2H, t, J 5.9, CH2OH), 4.13 (2H, t, J 5.9, CH2O), 6.83 (2H, d, J
8.4, ArH), 7.10 (2H, d, J 8.4, ArH). dC (CDCl3) 20.0 (CH3), 29.3
(CH2), 37.3 (CH2), 66.9 (CH2), 114.0 (CH), 129.3 (CH), 142.4 (C),
156.4 (C).
Reaction of Substrate 14h with Donor 3. Similarly: 2-
(3-(4-iodo-3-methoxy-3-methylbutoxy)propoxy)-naphthalene 14h
(147 mg, 0.33 mmol,
1
eq.) was reacted with 3,3¢-
(propane-1,3-diyl)bis(1-methyl-1H-benzo[d]imidazol-3-ium) io-
dide 31 (336 mg, 0.6 mmol, 1.8 eq.) to afford 2-(4-(3-methoxy-3-
methylbutoxy)butoxy)naphthalene 30h (36 mg, 38%) as a colour-
less oil and 4-(naphthalen-2-yloxy)butan-1-ol 16h (9 mg, 12%) as
a white solid.
30h (Found: [M+H]+ 317.2114. C20H28O3 (M) requires [M+H]+
317.2111). nmax(neat)/cm-1 2926, 2856, 1629, 1601, 1465, 1217,
1118, 1084, 836; dH (CDCl3) 1.20 (6H, s, 2 ¥ CH3), 1.82–1.98 (6H,
m, 3 ¥ CH2), 3.21 (3H, s, OCH3), 3.51–3.55 (4H, m, 2 ¥ CH2O),
4.16 (2H, t, J 6.2, CH2OH) 7.15–7.19 (2H, m, ArH), 7.44 (1H, t,
J 6.0, ArH), 7.48 (1H, t, J 6.9, ArH), 7.74–7.80 (3H, m, ArH);
dC (CDCl3) 24.9 (CH3), 25.7 (CH2), 26.0 (CH2), 38.7 (CH2), 48.7
(CH2), 66.6 (CH2), 67.3 (CH2), 70.2 (CH2), 73.2 (C), 106.0 (CH),
118.4 (CH), 123.0 (CH), 125.7 (CH), 126.1 (CH), 127.2 (CH),
128.4 (C), 128.8 (CH), 134.1 (C).
Reaction of Substrate 14f with Donor 3. Similarly: 1-(3-(4-
iodo-3-methoxy-3-methylbutoxy)propoxy)-4-methylbenzene 14f
(135 mg, 0.33 mmol, 1.0 eq.) was reacted with the 3,3¢-
(propane-1,3-diyl)bis(1-methyl-1H-benzo[d]imidazol-3-ium) io-
dide 31 (336 mg, 0.6 mmol, 1.8 eq.) to afford 1-(4-(3-methoxy-
3-methylbutoxy)butoxy)-4-methylbenzene 30f as a colourless oil
(22 mg, 24%) and 4-(p-tolyloxy)butan-1-ol 16f as a colourless oil
(7 mg, 8%).
30f: nmax(neat)/cm-1 2929, 2868, 1613, 1509, 1240, 1108, 812,
765; dH (CDCl3) 1.21 (6H, s, 2 ¥ CH3), 1.77–1.88 (6H, m, 3 ¥
CH2), 2.30 (3H, s, CH3), 3.21 (3H, s, OCH3), 3.48–3.54 (4H, m,
2 ¥ CH2O), 3.99 (2H, t, J 6.4, OCH2), 6.81 (2H, d, J 8.4, ArH),
7.10 (2H, d, J 8.4, ArH); dC (CDCl3) 19.9 (CH3), 24.9 (CH3), 25.7
(CH2), 25.9 (CH2), 38.7 (CH2), 48.7 (CH3), 66.6 (CH2), 67.2 (CH2),
70.1 (CH2), 73.3 (C) 113.9 (CH), 129.3 (CH), 129.4 (C), 156.4 (C).
16f: (Found: [M+NH4]+ 198.2435. C11H16O2 (M) requires
[M+NH4]+ 198.2435); nmax(neat)/cm-1 3273, 2953, 2872, 1513,
1471, 827; dH (CDCl3) 2.00–2.07 (2H, quintet, J 5.9, CH2), 3.89
(2H, t, J 5.9, CH2OH), 4.13 (2H, t, J 5.9, CH2O), 6.83 (2H, d, J
8.4, ArH), 7.10 (2H, d, J 8.4, ArH). dC (CDCl3) 19.9 (CH2), 25.4
(CH2), 29.1 (CH3), 62.1 (CH2), 67.4 (CH2), 113.9 (CH), 129.3 (C),
129.4 (CH).
◦
16h M.Pt. 118–120 C. (Found: [M+H]+ 217.1224. C14H16O2
(M) requires [M+H]+ 217.1223);nmax(neat)/cm-1 3238, 2956, 2931,
2878, 1629, 1600, 1389, 1261, 1040, 838, 749; dH (CDCl3) 1.82–
1.87 (2H, m, CH2), 1.95–2.07 (2H, m, CH2), 3.78 (2H, t, J 6.2,
CH2O), 4.16 (2H, t, J 6.2, CH2OH), 7.15–7.19 (2H, m, ArH),
7.44 (1H, t, J 6.0, ArH), 7.48 (1H, t, J 6.9, ArH), 7.74–7.80 (3H,
m, ArH); dC (CDCl3) 25.8 (CH2), 29.5 (CH2), 62.7 (CH2), 67.8
(CH2), 106.7 (CH), 118.9 (CH), 123.7 (CH), 126.4 (CH), 126.8
(CH), 127.6 (CH), 129.0 (C), 129.4 (CH), 134.6 (C), 156.9 (C).
D. Preparation and Reactions of Substrate 33
(Z)-4-(3-phenylpropoxy)-but-2-en-1-ol. (Z)-But-2-ene-1,4-
diol (16.5 mL, 200 mmol, 1.1 eq) was added dropwise to a stirred
suspension of sodium hydride (60% in mineral oil, 0.88 g, 22 mmol,
10 eq) in dry DMF (10 mL) at 0 ◦C and under argon. After
20 min, 1-bromo-3-phenylpropane (3.04 mL, 20 mmol, 1 eq) was
added dropwise and the reaction was left to stir at 0 ◦C for
1 h and heated to 90 ◦C for 24 h. The reaction mixture was
poured into water (30 mL) and extracted with diethyl ether (3 ¥
100 mL). The combined organic layers were washed with water
(2 ¥ 100 mL), brine (100 mL), dried over NaSO4 and concentrated
under reduced pressure. The crude product was purified using
silica gel chromatography, eluting with diethyl ether/PE (1 : 1),
to afford (Z)-4-(3-phenylpropoxy)-but-2-en-1-ol as a yellow oil
(2.84 g, 68%);1 nmax(neat)/cm-1 3393, 2931, 2861, 1454, 1102, 699;
dH (CDCl3) 1.93 (2H, m, CH2), 2.70 (2H, t, J 7.9, CH2Ar), 3.46
(2H, t, J 6.8, CH3O), 4.05 (2H, t, J 6.6, CH2O), 4.22 (2H, t,
J 7.0, CH2O), 5.71–5.75 (1H, m, CH = CH), 5.80–5.84 (1H, m,
CH = CH), 7.24–7.27 (3H, m, ArH), 7.33–7.37 (2H, m, ArH);
dC (CDCl3) 31.3 (CH2), 32.3 (CH2), 58.8 (CH2), 66.5 (CH2), 69.9
(CH2), 125.8 (CH), 128.3 (CH), 128.4 (CH), 128.5 (CH), 132.1
(CH), 141.8 (C). m/z (CI+) 224 [(M+ NH4)+, 100%] 207 (95), 189
(50), 118 (30).
Reaction of Substrate 14g with Donor 3. Similarly: 2-
(3-(4-iodo-3-methoxy-3-methylbutoxy)propoxy)-naphthalene 14g
(143 mg, 0.33 mmol, 1.0 eq.) was reacted with 3,3¢-
(propane-1,3-diyl)bis(1-methyl-1H-benzo[d]imidazol-3-ium) io-
dide 31 (336 mg, 0.6 mmol, 1.8 eq.) to afford 2-(3-(3-methoxy-3-
methylbutoxy)propoxy)naphthalene 30g as a colourless oil (32 mg,
29%) and 3-(naphthalen-2-yloxy)propan-1-ol 16g as a white solid
(8 mg, 15%).
30g (Found: [M+H]+ 303.4079. C19H26O3 (M) requires [M+H]+
303.4079); nmax(neat)/cm-1 2923, 2868, 1509, 1246, 1114, 815. dH
(CDCl3) 1.17 (6H, s, 2 ¥ CH3), 1.83 (2H, t, J 7.3, CH2), 2.09–
2.13 (2H, quintet, J 7.3, CH2), 3.19 (3H, s, CH3), 3.55 (2H, t, J
6.0, CH2O), 3.64 (2H, t, J 6.0, CH2O), 4.19 (2H, t, J 6.3, CH2),
7.14–7.16 (2H, m, ArH), 7.34 (1H, t, J 6.0, ArH), 7.42 (1H, t, J
6.9, ArH), 7.71–7.78 (3H, m, ArH); dC (CDCl3) 25.4 (CH3), 29.8
(CH2), 39.2 (CH2), 49.2 (CH3), 65.0 (CH2), 67.2 (CH2), 67.4 (CH2),
73.8 (C), 106.7 (CH), 119.0 (CH), 123.5 (CH), 126.3 (CH), 126.7
(CH), 127.6 (CH), 128.9 (C), 129.3 (CH), 134.7 (C), 157.0 (C).
16g;17 M.Pt. 99–100 ◦C. nmax(neat)/cm-1 3273, 2953, 2872, 1513,
1471, 827; dH (CDCl3) 2.11–2.20 (2H, m, CH2), 3.94 (2H, t, J 6.0
CH2O), 4.27 (2H, t, J 6.0, CH2OH), 7.15–7.19 (2H, m, ArH),
7.44 (1H, t, J 6.0, ArH), 7.48 (1H, t, J 6.9, ArH), 7.74–7.80 (3H,
m, ArH); dC (CDCl3) 31.5 (CH2), 60.1 (CH2), 65.3 (CH2), 106.2
(CH), 118.3 (CH), 123.2 (CH), 125.9 (CH), 126.3 (CH), 127.1
(CH), 128.5 (C), 128.9 (CH), 134.0 (C), 156.4 (C).
1-(3-((Z)-4-(2-iodophenoxy)but-2-enyloxy)propyl)benzene 33.
To a stirred solution of (Z)-4-(3-phenylpropoxy)but-2-en-1-ol
(1.50 g, 7.27 mmol, 1 eq), 2-iodophenol (1.92 g, 8.73 mmol,
1.2 eq) and triphenylphosphine (2.86 g, 10.91 mmol, 1.5 eq) in
THF (20 mL) at 0 ◦C was added diisopropyl azodicarboxylate
(2.16 mL, 10.91 mmol, 1.5eq) and the mixture was allowed to
warm to rt overnight. After evaporation of the solvent under
3568 | Org. Biomol. Chem., 2011, 9, 3560–3570
This journal is
The Royal Society of Chemistry 2011
©